Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.82 USD
Change Today 0.00 / 0.00%
Volume 328.4K
XNPT On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul L. Berns

Independent Director and Chairman of Compensation Committee,Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 43 board members in 6 different organizations across 8 different industries.

See Board Relationships


Mr. Paul L. Berns has been the Chief Executive Officer and President at Anacor Pharmaceuticals, Inc. since March 2014 and has been serves as its Chairman since June 2013. Mr. Berns served as the Chief Executive Officer and President of Allos Therapeutics Inc. from March 9, 2006 to August 2012. He was a self-employed consultant to the pharmaceutical industry from July 2005 to March 2006. He served as the President and Chief Executive Officer at Bone Care International ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

Vice President of Marketing
Independent Director and Chairman of Compensation Committee
Chairman, Chief Executive Officer and President
Director, Member of Compensation Committee and Member of Audit Committee
Chairman of The Board, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee


University of Wisconsin - Madison

Other Affiliations*

Annual Compensation*

Total Annual Compensation$456,970

Stock Options*

Restricted Stock Awards$7,256,500
All Other Compensation$574
Exercisable Options144,000
Exercisable Options Value$2,296,360
Unexercisable Options310,000
Unexercisable Options Value$3,582,500
Total Value of Options$5,878,860
Total Number of Options454,000

Total Compensation*

Total Annual Cash Compensation$985,607
Total Short Term Compensation$456,970
Other Long Term Compensation$7,257,074
Total Calculated Compensation$14,132,317
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $6.82 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at